In the last trading session, 0.74 million shares of the Relmada Therapeutics Inc (NASDAQ:RLMD) were traded, and its beta was 0.14. Most recently the company’s share price was $0.38, and it changed around $0.01 or 4.96% from the last close, which brings the market valuation of the company to $12.72M. RLMD currently trades at a discount to its 52-week high of $4.47, offering almost -1076.32% off that amount. The share price’s 52-week low was $0.24, which indicates that the current value has risen by an impressive 36.84% since then.
Relmada Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 3 recommended RLMD as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Relmada Therapeutics Inc (NASDAQ:RLMD) trade information
Instantly RLMD has showed a green trend with a performance of 4.96% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.3978 on recent trading dayincreased the stock’s daily price by 4.47%. The company’s shares are currently down -26.31% year-to-date, but still up 7.31% over the last five days. On the other hand, Relmada Therapeutics Inc (NASDAQ:RLMD) is 38.89% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to increase their stock price by 94.57% from its current value. Analyst projections state that RLMD is forecast to be at a low of $2 and a high of $8.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 0.68%. Relmada Therapeutics Inc earnings are expected to increase by 34.72% in 2025, but the outlook is positive 19.94% per year for the next five years.
RLMD Dividends
Relmada Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
DEEP TRACK CAPITAL, LP, with 16.3686% or 1.23 million shares worth $3.7 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND were the top two Mutual Funds as of Dec 31, 2024 . The former held 851.92 shares worth $0.33 million, making up 8.61% of all outstanding shares. On the other hand, Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND held roughly 456.4 shares worth around $0.17 million, which represents about 4.61% of the total shares outstanding.
